Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive ...
SALT LAKE CITY, May 07, 2018 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that results from a large, well-controlled pharmacogenomics study in patients with major depressive disorder …